Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.3 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |